Effects of salicylate on the pharmacokinetics of valproic acid after oral administration of sodium valproate in rats

Biogenic Amines

Volumn 17, Issue 4-6, 2003, Pages 401-407

  Ohshiro, S ^a   Hobara, N ^a   Sakai, M ^a   Hokama, N ^a   Kameya, H ^a   Sakanashi, M ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Pharmacokinetics; Rat; Salicylate; Valproic acid

Indexed keywords

CARBOXYMETHYLCELLULOSE; SALICYLATE SODIUM; SALICYLIC ACID; VALPROIC ACID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0141592578     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: 10.1163/15693910260698348     Document Type: Article

References (13)

1. Abbott, F. S., Kassan, J., Orr, J. M., et al. (1986). The effect of aspirin on valproic acid metabolism, Clin. Pharmacol. Ther. 40, 94-100.
2. Brodie, B. B. and Hogben, C. A. M. (1957). Some physico-chemical factors in drug action, J. Pharm. Pharmacol. 9, 345-380.
3. Feitman, J. S., Bruni, J., Perrin, J. H., et al. (1980). Albumin binding interactions of sodium valproate, J. Clin. Pharmcol. 20, 514-517.
4. Flower, R. J., Moncada, S. and Vane, J. R. (1985). Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of gout, in: The Pharmacological Basis of Therapeutics, Gilman, A. G., Goodman, L. S., Rall, T. W. and Murad, F. (Eds), 7th edn, pp. 674-715. Macmillan, New York.
5. Fogh, J., Fogh, J. M. and Orfeo, T. (1977). One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice, J. Natl. Cancer Inst. 59, 221-226.
6. Gugler, R. and Von Unruh, G. E. (1980). Clinical pharmacokinetics of valproic acid, Clin. Pharmacokinet. 5, 67-83.
7. Higalgo, I. J., Raub, T. J. and Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology 96, 736-749.
8. Iwamoto, K., Takei, M. and Watanabe, J. (1982). Gastrointestinal and hepatic first-pass metabolism of aspirin in rats, J. Pharm. Pharmacol. 34, 176-180.
9. Kaiji, H., Horie, T., Hayasi, M., et al. (1986). Effect of salicylic acid on the permeability of the plasma membrane of the small intestine of the rat: a fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption, J. Pharm. Sci. 75, 475-478.
10. Orr, J. M., Abott, F. S., Farell, K., et al. (1982). Interaction between valproic acid and aspirin in epileptic children: Serum protein binding and metabolic effects, Clin. Pharmacol. Ther. 31, 642-649.
11. Takanaga, H., Tamai, I. and Tsuji, A. (1994). pH-Dependent and carrier-mediated transport of salicylic acid across Caco-2 cells, J. Pharm. Pharmacol. 46, 567-570.
12. Tsuji, A., Takanaga, H., Tamai, I., et al. (1994). Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism, Pharm. Res. 11, 30-37.
13. Yu, H. Y., Shen, Y. Z., Sugiyama, Y., et al. (1990). Effects of salicylate on pharmacokinetics of valproic acid in rats, Drug Metab. Dispos. 18, 121-126.